Molecular Genetics and Genomics Molecular Biology

Plasma proteome-driven discovery of therapeutic targets for age-related macular degeneration: a multi-omics mendelian randomization framework

Xiang, Zhaoyu, Huang, Wenjia, Zhao, Xiaohuan, Zhou, Minwen, Huang, Xiaoxu, Wang, Shiming
Springer Nature · 2026-11-07 · DOI 10.1007/s00438-026-02544-7

Abstract

This study aimed to prioritize potential therapeutic candidates for age-related macular degeneration (AMD) using an integrated multi-omics Mendelian randomization (MR) framework. We performed two-sample MR using 2,816 cis-pQTLs from four proteome-wide association studies to identify AMD-associated plasma proteins. Validation included summary-based MR (SMR), colocalization, protein–protein interaction analysis, pathway enrichment, retinal expression profiling, and druggability assessment. We identified 22 AMD-associated proteins, including both known (e.g., CFB, APOE, C3) and novel candidates (e.g., CTRL, LCAT, TNFRSF10A). Four targets (C3, CTRL, LCAT, TNFRSF10A) were prioritized as Tier 1 candidates based on consistent MR and colocalization evidence. These targets were enriched in complement activation, coagulation, and lipid metabolism pathways. This study proposed 22 potential therapeutic targets for AMD, with C3, CTRL, LCAT, and TNFRSF10A representing high-confidence candidates for further mechanistic and clinical investigation.

Read at publisher →